Senior insider sale
SVP, Head of Res./Clin. Dev. at ABEONA THERAPEUTICS INC. — senior position signals high conviction
$435.9K
87.96K shares
What this filing means
SESHADRI VISHWAS plans to sell 87.96K shares of ABEONA THERAPEUTICS INC. valued at approximately $435.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/8/2026ACC: 0001972481-26-000185
Officer· SVP, Head of Res./Clin. Dev.
Since Jun 2021
87.96K
Shares to sell
$435.9K
Approx. market value
112.28K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Awards
Equity Compensation
6/5/2026
112.28KTotal acquired112.28K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/5/2026 | Restricted Stock Awards Equity Compensation | 112.28K | — |
| Total | 112.28K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
29.96K
Market value
$131.4K
3/31/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
58K
Market value
$304.5K
6/8/2026
Total
Units
87.96K
Value
$435.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/31/2026 | 29.96K | $131.4K | — | Completed |
| Planned — Approximate Date | ||||
6/8/2026 | 58K | $304.5K | Nasdaq | Planned |
| Total | 87.96K | $435.9K | ||